AllerFund: Comprehensive healthcare, diagnostics, and treatments for food allergies.
Location
Scarsdale, NY, US
Founded
2020
AllerFund is a venture capital firm focused on driving social impact in the food allergy community. They invest in companies developing treatments, diagnostics, and products for individuals with food allergies. While specific investment sizes are not disclosed, AllerFund supports companies across various stages, from seed to Series B rounds.
Notable portfolio companies include Alladapt Immunotherapeutics, Allergy Amulet, Bryn Pharma, and IgGenix. As the first VC firm dedicated to food allergies, AllerFund brings specialized expertise to its investments, supporting innovations that improve the lives of those affected by food allergies. Their unique focus positions them as a valuable partner for startups in this niche healthcare sector.
AllerFund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
